Skip to content

To evaluate the role of homoeopathic medicines (LM vis-a-vis centesimal) in uterine fibroids

A Multicentric Randomized Clinical trial of Homeopathic Medicines in LM potencies vis-a-vis Centesimal potencies on Symptomatic Uterine Fibroids. - UF

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/12/002211
Enrollment
280
Registered
2011-12-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Uterine fibroid

Interventions

Intervention1: Homoeopathic therapy: homoeopathic therapy Intervention2: Homeopathic Medicines in LM potencies: LM potencies- 15 ml once daily or as required for 1 year orally Control Intervention1:

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Pre-menopausal women (18-45 years of age). 2 Any of the symptoms like abnormal uterine bleeding (profuse menstruation or inter-cyclic menstruation), pelvic heaviness, pain during menstruation, pain during intercourse, pressure symptoms like urinary frequency, constipation. 3 Uterine fibroids confirmed by pelvic and/or transvaginal ultrasonography. 4 If patient is taking Oral contraceptive pills (OCP) then the patient shall be advised to stop pills till it exhausts for the ongoing cycle which shall be followed by symptom assessment, investigations and enrolment. 5 Diabetic patients with HbA1C less than equal to 8 %.

Exclusion criteria

Exclusion criteria: 1Calcified fibroid 2Coagulation disorders 3Patients with extra uterine fibroid 4Fibroid polyp 5Cervical fibroid 6Any fibroid causing hydronephrosis. 7Fibroid with solid ovarian mass 8 Hb. less than 7 gm/dl (severe anemia). 9Inability to comply with the study protocol, including psychiatric diseases 10Pregnant women. 11Malignant condition of genito-urinary tract. 12 H/O any other malignancy. 13 Patient desiring immediate surgical management for uterine fibroid. 14 Women with a desire for child bearing in the next year 15 Patients insisting to use OCP (oral contraceptive pills)

Design outcomes

Secondary

MeasureTime frame
Uterine Fibroid Symptom-Quality of Life (UFS-QOL)Timepoint: Baseline, 6months, 12 months

Primary

MeasureTime frame
Visual Analog scale for symptoms of uterine fibroidTimepoint: baseline, monthly, 12 months

Countries

India

Contacts

Public ContactDr Praveen Oberai

Central Council for Research in Homoeopathy

oberai.praveen@gmail.com09811952274

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026